CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
London, United Kingdom and 70 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
London, United Kingdom and 111 other locations
This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation...
Phase 2
London, United Kingdom and 45 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Chertsey, Surrey, United Kingdom and 157 other locations
12 years old with moderate to severe asthma....
Phase 2
London, United Kingdom and 22 other locations
The United Kingdom has a high prevalence of asthma (over 12%) and some of the worst health outcomes in Europe. The management of respiratory...
London, England, United Kingdom
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
London, United Kingdom and 335 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
London, United Kingdom and 141 other locations
A Phase IIa trial in participants with asthma to evaluate the impact of intranasal ETH47 on the development of asthma-related sympt...
Phase 2
London, United Kingdom
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Chertsey, Surrey, United Kingdom and 83 other locations
Clinical trials
Research sites
Resources
Legal